Use of Natural Language Processing to Extract Clinical Cancer Phenotypes from Electronic Medical Records.
暂无分享,去创建一个
Georgia Tourassi | Jeremy L Warner | Danielle S Bitterman | Chen Lin | Folami Alamudun | Timothy Miller | Ioana Danciu | Folami T. Alamudun | Guergana K Savova | G. Tourassi | J. Warner | Chen Lin | G. Savova | Timothy Miller | I. Danciu | D. Bitterman
[1] Morten Nielsen,et al. The PickPocket method for predicting binding specificities for receptors based on receptor pocket similarities: application to MHC-peptide binding , 2009, Bioinform..
[2] Steven L Salzberg,et al. HISAT: a fast spliced aligner with low memory requirements , 2015, Nature Methods.
[3] Collin Tokheim,et al. Evaluation of machine learning methods to predict peptide binding to MHC Class I proteins , 2017, bioRxiv.
[4] Alessandro Sette,et al. Generating quantitative models describing the sequence specificity of biological processes with the stabilized matrix method , 2005, BMC Bioinformatics.
[5] Kam Y. J. Zhang,et al. Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity , 2008, Proceedings of the National Academy of Sciences.
[6] J. Gartner,et al. Unique neoantigens arise from somatic mutations in patients with gastrointestinal cancers. , 2019, Cancer discovery.
[7] Kate Voss,et al. Full-stack genomics pipelining with GATK4 + WDL + Cromwell , 2017 .
[8] A. Spurdle,et al. Most common 'sporadic' cancers have a significant germline genetic component. , 2014, Human molecular genetics.
[9] Morten Nielsen,et al. NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8–11 , 2008, Nucleic Acids Res..
[10] Shyam Visweswaran,et al. Automated annotation and classification of BI-RADS assessment from radiology reports , 2017, J. Biomed. Informatics.
[11] L. Skarsgard,et al. Dose dependence of the oxygen enhancement ratio (OER) in radiation inactivation of Chinese hamster V79-171 cells. , 1991, Radiation Research.
[12] Joshy George,et al. Whole–genome characterization of chemoresistant ovarian cancer , 2015, Nature.
[13] Hong Yu,et al. Structured prediction models for RNN based sequence labeling in clinical text , 2016, EMNLP.
[14] The problem with neoantigen prediction , 2017, Nature Biotechnology.
[15] Bjoern Peters,et al. Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries , 2008, Immunome research.
[16] M. Ringnér,et al. Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma , 2017, Nature Communications.
[17] P. A. Futreal,et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.
[18] Barbara L. Smith,et al. Pathologic findings in reduction mammoplasty specimens: a surrogate for the population prevalence of breast cancer and high-risk lesions , 2018, Breast Cancer Research and Treatment.
[19] G. Gallia,et al. Multiple resections for patients with glioblastoma: prolonging survival. , 2013, Journal of neurosurgery.
[20] C. Dominici,et al. Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines , 2019, Journal of Endocrinological Investigation.
[21] Anton Nekrutenko,et al. Ten Simple Rules for Reproducible Computational Research , 2013, PLoS Comput. Biol..
[22] Ji-Xin Cheng,et al. Ex vivo and in vivo imaging of myelin fibers in mouse brain by coherent anti-Stokes Raman scattering microscopy. , 2008, Optics express.
[23] Robert E. Schapire,et al. The Boosting Approach to Machine Learning An Overview , 2003 .
[24] Joshua A. Bittker,et al. Harnessing Connectivity in a Large-Scale Small-Molecule Sensitivity Dataset. , 2015, Cancer discovery.
[25] Geoffrey E. Hinton,et al. Deep Learning , 2015, Nature.
[26] R G Dale,et al. The application of the linear-quadratic dose-effect equation to fractionated and protracted radiotherapy. , 1985, The British journal of radiology.
[27] J. Sarkaria,et al. Combining precision radiotherapy with molecular targeting and immunomodulatory agents: a guideline by the American Society for Radiation Oncology. , 2018, The Lancet. Oncology.
[28] P. Marynen,et al. Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants. , 2005, Gastroenterology.
[29] Bjoern Peters,et al. HLA class I supertypes: a revised and updated classification , 2008, BMC Immunology.
[30] James Pustejovsky,et al. SemEval-2016 Task 12: Clinical TempEval , 2016, NAACL 2016.
[31] J. Manson,et al. Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer. , 2007, Cancer research.
[32] Christopher R. Cabanski,et al. cDNA hybrid capture improves transcriptome analysis on low-input and archived samples. , 2014, The Journal of molecular diagnostics : JMD.
[33] Adam P Dicker,et al. Development and validation of a 24-gene predictor of response to postoperative radiotherapy in prostate cancer: a matched, retrospective analysis. , 2016, The Lancet. Oncology.
[34] T. Mikkelsen,et al. Identification of regions of normal grey matter and white matter from pathologic glioblastoma and necrosis in frozen sections using Raman imaging , 2015, Journal of Neuro-Oncology.
[35] Stephen T. C. Wong,et al. Chemically-selective imaging of brain structures with CARS microscopy. , 2007, Optics express.
[36] Alastair J. King,et al. Discovery of Dabrafenib: A Selective Inhibitor of Raf Kinases with Antitumor Activity against B-Raf-Driven Tumors. , 2013, ACS medicinal chemistry letters.
[37] Abhishek Pandey,et al. Natural language processing systems for capturing and standardizing unstructured clinical information: A systematic review , 2017, J. Biomed. Informatics.
[38] D. Tindall,et al. Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation. , 2015, Cancer research.
[39] Mithat Gönen,et al. Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer , 2017, Nature.
[40] Timothy L. Tickle,et al. STAR-Fusion: Fast and Accurate Fusion Transcript Detection from RNA-Seq , 2017, bioRxiv.
[41] E. Jaffee,et al. Targeting neoantigens to augment antitumour immunity , 2017, Nature Reviews Cancer.
[42] V. Lewis,et al. Current and future therapeutic approaches for osteosarcoma , 2018, Expert review of anticancer therapy.
[43] E. Birney,et al. The topography of mutational processes in breast cancer genomes , 2016, Nature Communications.
[44] Geoffrey S. Tobias,et al. Family history of cancer and risk of pancreatic cancer: A pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan) , 2010, International journal of cancer.
[45] Ash A. Alizadeh,et al. Profiling Tumor Infiltrating Immune Cells with CIBERSORT. , 2018, Methods in molecular biology.
[46] D. Albanes,et al. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. , 2005, JAMA.
[47] A. Lazar,et al. Estrogen receptor alpha and androgen receptor are commonly expressed in well-differentiated liposarcoma , 2014, BMC Clinical Pathology.
[48] G. Getz,et al. Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer , 2017, Nature Communications.
[49] Marc R. Birtwistle,et al. Drug response consistency in CCLE and CGP , 2016, Nature.
[50] Johannes G. Reiter,et al. Minimal functional driver gene heterogeneity among untreated metastases , 2018, Science.
[51] Lior Pachter,et al. Near-optimal probabilistic RNA-seq quantification , 2016, Nature Biotechnology.
[52] Bjoern Peters,et al. HLA Class I Alleles Are Associated with Peptide-Binding Repertoires of Different Size, Affinity, and Immunogenicity , 2013, The Journal of Immunology.
[53] Li Ding,et al. Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma. , 2014, Cell reports.
[54] Angelika Unterhuber,et al. Imaging ex vivo healthy and pathological human brain tissue with ultra-high-resolution optical coherence tomography. , 2005, Journal of biomedical optics.
[55] J. Fujimoto,et al. Optical coherence tomography: an emerging technology for biomedical imaging and optical biopsy. , 2000, Neoplasia.
[56] Paul Fockens,et al. International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer , 2012, Gut.
[57] J. Torres-Roca,et al. Predicting response to clinical radiotherapy: past, present, and future directions. , 2008, Cancer control : journal of the Moffitt Cancer Center.
[58] Robert Gentleman,et al. Statistical Applications in Genetics and Molecular Biology , 2005 .
[59] Christoph U. Lehmann,et al. Electronic Health Record Interactions through Voice: A Review , 2018, Applied Clinical Informatics.
[60] Jennifer G. Abelin,et al. Mass Spectrometry Profiling of HLA‐Associated Peptidomes in Mono‐allelic Cells Enables More Accurate Epitope Prediction , 2017, Immunity.
[61] S. Brunak,et al. Prediction of proteasome cleavage motifs by neural networks. , 2002, Protein engineering.
[62] A. Quiñones‐Hinojosa,et al. Advances in Brain Tumor Surgery for Glioblastoma in Adults , 2017, Brain sciences.
[63] Luca Toschi,et al. Preexistence and clonal selection of MET amplification in EGFR mutant NSCLC. , 2010, Cancer cell.
[64] Olivier Elemento,et al. AGFusion: annotate and visualize gene fusions , 2016, bioRxiv.
[65] Joshua C. Gilbert,et al. An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules , 2013, Cell.
[66] Steven Eschrich,et al. Prediction of radiation sensitivity using a gene expression classifier. , 2005, Cancer research.
[67] M. Nielsen,et al. NetMHCpan-4.0: Improved Peptide–MHC Class I Interaction Predictions Integrating Eluted Ligand and Peptide Binding Affinity Data , 2017, The Journal of Immunology.
[68] A. Goto,et al. Increased Levels of Branched-Chain Amino Acid Associated With Increased Risk of Pancreatic Cancer in a Prospective Case-Control Study of a Large Cohort. , 2018, Gastroenterology.
[69] Hongfang Liu,et al. CLAMP – a toolkit for efficiently building customized clinical natural language processing pipelines , 2017, J. Am. Medical Informatics Assoc..
[70] Benjamin Schubert,et al. OptiType: precision HLA typing from next-generation sequencing data , 2014, Bioinform..
[71] Kevin Petrecca,et al. Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma , 2012, Journal of Neuro-Oncology.
[72] David Gfeller,et al. Current tools for predicting cancer-specific T cell immunity , 2016, Oncoimmunology.
[73] T. Hastie,et al. Automated Survival Prediction in Metastatic Cancer Patients Using High-Dimensional Electronic Medical Record Data. , 2018, Journal of the National Cancer Institute.
[74] Peter Spyns. Natural Language Processing in Medicine: An Overview , 1996, Methods of Information in Medicine.
[75] Felix Y. Feng,et al. Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer , 2015, Clinical Cancer Research.
[76] Nasrollah Erfani,et al. Structural vaccinology considerations for in silico designing of a multi-epitope vaccine. , 2018, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[77] D. Elder,et al. The role of BRAF mutation and p53 inactivation during transformation of a subpopulation of primary human melanocytes. , 2009, The American journal of pathology.
[78] David E Larson,et al. Using VarScan 2 for Germline Variant Calling and Somatic Mutation Detection , 2013, Current protocols in bioinformatics.
[79] L. Choo-Smith,et al. Discriminating Vital Tumor from Necrotic Tissue in Human Glioblastoma Tissue Samples by Raman Spectroscopy , 2002, Laboratory Investigation.
[80] A. McKenna,et al. The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma. , 2014, Cancer discovery.
[81] Malachi Griffith,et al. pVACtools: A Computational Toolkit to Identify and Visualize Cancer Neoantigens , 2020, Cancer Immunology Research.
[82] Shang Gao,et al. Hierarchical attention networks for information extraction from cancer pathology reports , 2017, J. Am. Medical Informatics Assoc..
[83] Yusuke Nakamura,et al. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer , 2014, Nature Genetics.
[84] Florian Engert,et al. Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency , 2015, Nature Communications.
[85] Kenneth H. Buetow,et al. Bioinformatics Applications Note Sequence Analysis Bambino: a Variant Detector and Alignment Viewer for Next-generation Sequencing Data in the Sam/bam Format , 2022 .
[86] Zoltan Szallasi,et al. MuPeXI: prediction of neo-epitopes from tumor sequencing data , 2017, Cancer Immunology, Immunotherapy.
[87] Jin Zhang,et al. INTEGRATE-neo: a pipeline for personalized gene fusion neoantigen discovery , 2016, Bioinform..
[88] Hua Xu,et al. Data from clinical notes: a perspective on the tension between structure and flexible documentation , 2011, J. Am. Medical Informatics Assoc..
[89] J. Hammerbacher,et al. Vaxrank: A computational tool for designing personalized cancer vaccines , 2017, bioRxiv.
[90] T. Mikkelsen,et al. Raman spectroscopy to distinguish grey matter, necrosis, and glioblastoma multiforme in frozen tissue sections , 2014, Journal of Neuro-Oncology.
[91] Brian S. Finkelman,et al. A clinical prediction model to assess risk for pancreatic cancer among patients with new-onset diabetes. , 2017 .
[92] Henry Brem,et al. Supratentorial Glioblastoma Multiforme: The Role of Surgical Resection Versus Biopsy Among Older Patients , 2010, Annals of Surgical Oncology.
[93] Eric Fosler-Lussier,et al. Automatic data source identification for clinical trial eligibility criteria resolution , 2016, AMIA.
[94] Myles A Brown,et al. An Integrative Pharmacogenomic Approach Identifies Two-drug Combination Therapies for Personalized Cancer Medicine , 2016, Scientific Reports.
[95] Alan R. Aronson,et al. Effective mapping of biomedical text to the UMLS Metathesaurus: the MetaMap program , 2001, AMIA.
[96] E. Lankenau,et al. Imaging of human brain tumor tissue by near-infrared laser coherence tomography , 2009, Acta Neurochirurgica.
[97] Eytan Ruppin,et al. Predicting Cancer-Specific Vulnerability via Data-Driven Detection of Synthetic Lethality , 2014, Cell.
[98] S. Salzberg,et al. TopHat-Fusion: an algorithm for discovery of novel fusion transcripts , 2011, Genome Biology.
[99] Mauricio O. Carneiro,et al. From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline , 2013, Current protocols in bioinformatics.
[100] J. Manson,et al. A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts. , 2013, Journal of the National Cancer Institute.
[101] Habib Zaidi,et al. Quantitative analysis of MRI-guided attenuation correction techniques in time-of-flight brain PET/MRI , 2016, NeuroImage.
[102] M. DePristo,et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data , 2011, Nature Genetics.
[103] O. Lund,et al. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ , 2013, Immunogenetics.
[104] Masaya Suenaga,et al. Deleterious Germline Mutations in Patients With Apparently Sporadic Pancreatic Adenocarcinoma. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[105] J. Manson,et al. Plasma 25-Hydroxyvitamin D and Risk of Pancreatic Cancer , 2011, Cancer Epidemiology, Biomarkers & Prevention.
[106] Todd Hollon,et al. Improving the accuracy of brain tumor surgery via Raman-based technology. , 2016, Neurosurgical focus.
[107] Hsin-Hsiung Huang,et al. Comparing logistic regression, support vector machines, and permanental classification methods in predicting hypertension , 2014, BMC Proceedings.
[108] B. Park,et al. Mutation of the PIK3CA oncogene in human cancers , 2006, British Journal of Cancer.
[109] A. Giese,et al. Time‐domain and spectral‐domain optical coherence tomography in the analysis of brain tumor tissue , 2006, Lasers in surgery and medicine.
[110] M. Knowles,et al. Knockdown by shRNA identifies S249C mutant FGFR3 as a potential therapeutic target in bladder cancer , 2007, Oncogene.
[111] Hong Yu,et al. Bidirectional RNN for Medical Event Detection in Electronic Health Records , 2016, NAACL.
[112] Alex Rubinsteyn,et al. MHCflurry: Open-Source Class I MHC Binding Affinity Prediction. , 2018, Cell systems.
[113] Raffaele Pezzilli,et al. Common variation at 2 p 13 . 3 , 3 q 29 , 7 p 13 and 17 q 25 . 1 associated with susceptibility to pancreatic cancer , 2022 .
[114] Morten Nielsen,et al. Pan-Specific Prediction of Peptide–MHC Class I Complex Stability, a Correlate of T Cell Immunogenicity , 2016, The Journal of Immunology.
[115] Hinrich Schütze,et al. Introduction to information retrieval , 2008 .
[116] J. Gartner,et al. Immunogenicity of somatic mutations in human gastrointestinal cancers , 2015, Science.
[117] John N Weinstein,et al. Integrating global gene expression and radiation survival parameters across the 60 cell lines of the National Cancer Institute Anticancer Drug Screen. , 2008, Cancer research.
[118] A. Carr,et al. CRL4Wdr70 regulates H2B monoubiquitination and facilitates Exo1-dependent resection , 2016, Nature Communications.
[119] Xingde Li,et al. Robust and fast characterization of OCT-based optical attenuation using a novel frequency-domain algorithm for brain cancer detection , 2017, Scientific Reports.
[120] K. Kohn,et al. DNA damage and repair in mouse leukemia L1210 cells treated with nitrogen mustard, 1,3-bis(2-chloroethyl)-1-nitrosourea, and other nitrosoureas. , 1977, Cancer research.
[121] Gonçalo R. Abecasis,et al. The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..
[122] Kristen Howell,et al. Improving Feature Extraction for Pathology Reports with Precise Negation Scope Detection , 2018, COLING.
[123] Herbert Yu,et al. Detectable Symptomatology Preceding the Diagnosis of Pancreatic Cancer and Absolute Risk of Pancreatic Cancer Diagnosis. , 2015, American journal of epidemiology.
[124] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[125] R. Weinberg,et al. A Perspective on Cancer Cell Metastasis , 2011, Science.
[126] Erik Cambria,et al. Recent Trends in Deep Learning Based Natural Language Processing , 2017, IEEE Comput. Intell. Mag..
[127] Geoffrey S. Tobias,et al. Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. , 2009, American journal of epidemiology.
[128] R. Karchin,et al. CHASMplus Reveals the Scope of Somatic Missense Mutations Driving Human Cancers. , 2019, Cell systems.
[129] H. Ishwaran,et al. Tumor Immunity and Survival as a Function of Alternative Neopeptides in Human Cancer , 2018, Cancer Immunology Research.
[130] Alison Callahan,et al. Performing an Informatics Consult: Methods and Challenges. , 2018, Journal of the American College of Radiology : JACR.
[131] J. Gartner,et al. Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens , 2016, Cancer Immunology Research.
[132] Alison P. Klein,et al. An Absolute Risk Model to Identify Individuals at Elevated Risk for Pancreatic Cancer in the General Population , 2013, PloS one.
[133] Mi Ni Huang,et al. In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumors , 2017, bioRxiv.
[134] Gregory W. Auner,et al. Raman molecular imaging of brain frozen tissue sections , 2014, Journal of Neuro-Oncology.
[135] M. Makary,et al. Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers , 2017, Proceedings of the National Academy of Sciences.
[136] C. Klabunde,et al. Linking Physician Characteristics and Medicare Claims Data: Issues in Data Availability, Quality, and Measurement , 2002, Medical care.
[137] Keith D. Paulsen,et al. δ-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy. , 2011, Neuro-oncology.
[138] L. Bernstein,et al. Intraoperative brain cancer detection with Raman spectroscopy in humans , 2015, Science Translational Medicine.
[139] Christian Dehlendorff,et al. Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer , 2018, Oncotarget.
[140] V. Velculescu,et al. High-throughput prediction of MHC Class I and Class II neoantigens with MHCnuggets , 2019, bioRxiv.
[141] Peter Kraft,et al. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer , 2018, Nature Communications.
[142] Alan R. Aronson,et al. An overview of MetaMap: historical perspective and recent advances , 2010, J. Am. Medical Informatics Assoc..
[143] M. McCarter,et al. Characteristics of 10-Year Survivors of Pancreatic Ductal Adenocarcinoma. , 2015, JAMA surgery.
[144] Larry Norton,et al. Tumor Self-Seeding by Circulating Cancer Cells , 2009, Cell.
[145] J. Mesirov,et al. Integrative radiogenomic profiling of squamous cell lung cancer. , 2013, Cancer research.
[146] J. Manson,et al. Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer. , 2013, Journal of the National Cancer Institute.
[147] D. Haussler,et al. ProTECT—Prediction of T-Cell Epitopes for Cancer Therapy , 2019, bioRxiv.
[148] B. Fertil,et al. Intrinsic radiosensitivity of human cell lines is correlated with radioresponsiveness of human tumors: analysis of 101 published survival curves. , 1985, International journal of radiation oncology, biology, physics.
[149] S. Molyneux,et al. Cross-species genomics identifies DLG2 as a tumor suppressor in osteosarcoma , 2018, Oncogene.
[150] Shuguang Huang,et al. Comparing statistical methods for quantifying drug sensitivity based on in vitro dose-response assays. , 2012, Assay and drug development technologies.
[151] Kai Ye,et al. Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads , 2009, Bioinform..
[152] George Coukos,et al. The Length Distribution and Multiple Specificity of Naturally Presented HLA-I Ligands , 2018, The Journal of Immunology.
[153] E. Prosperi,et al. CREBBP and p300 lysine acetyl transferases in the DNA damage response , 2017, Cellular and Molecular Life Sciences.
[154] O. Lund,et al. NetMHCpan, a Method for Quantitative Predictions of Peptide Binding to Any HLA-A and -B Locus Protein of Known Sequence , 2007, PloS one.
[155] G. Giaever,et al. DNA-damaging agents in cancer chemotherapy: serendipity and chemical biology. , 2013, Chemistry & biology.
[156] Olivier Ferret,et al. Neural Architecture for Temporal Relation Extraction: A Bi-LSTM Approach for Detecting Narrative Containers , 2017, ACL.
[157] Crispin J. Miller,et al. Investigation of Radiosensitivity Gene Signatures in Cancer Cell Lines , 2014, PloS one.
[158] T. Schumacher,et al. Neoantigens in cancer immunotherapy , 2015, Science.
[159] S. Biswal,et al. Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistance. , 2010, Antioxidants & redox signaling.
[160] I. Nookaew,et al. Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods , 2013, Nucleic acids research.
[161] Chen Lin,et al. Improving Temporal Relation Extraction with Training Instance Augmentation , 2016, BioNLP@ACL.
[162] L. Jensen,et al. Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation* , 2015, Molecular & Cellular Proteomics.
[163] Bjoern Peters,et al. Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes , 2011, Immunogenetics.
[164] H. Kocher,et al. Pancreatic Cancer , 2019, Methods in Molecular Biology.
[165] Benjamin Schubert,et al. Designing string-of-beads vaccines with optimal spacers , 2016, Genome Medicine.
[166] J. Baek,et al. Early experience with Watson for oncology in Korean patients with colorectal cancer , 2019, PloS one.
[167] S A Boppart,et al. Optical coherence tomography for neurosurgical imaging of human intracortical melanoma. , 1998, Neurosurgery.
[168] Dirk Verellen,et al. Innovations in image-guided radiotherapy , 2008, Nature Reviews Cancer.
[169] Michael C. Heinold,et al. The landscape of genomic alterations across childhood cancers , 2018, Nature.
[170] R. Langer,et al. The Women's Health Initiative Observational Study: baseline characteristics of participants and reliability of baseline measures. , 2003, Annals of epidemiology.
[171] Martin Villiger,et al. Automatic classification of atherosclerotic plaques imaged with intravascular OCT. , 2016, Biomedical optics express.
[172] Jeremy L Warner,et al. Automating the Determination of Prostate Cancer Risk Strata From Electronic Medical Records. , 2017, JCO clinical cancer informatics.
[173] O. Lund,et al. novel sequence representations Reliable prediction of T-cell epitopes using neural networks with , 2003 .
[174] Laurent Mahieu-Williame,et al. Two-peaked 5-ALA-induced PpIX fluorescence emission spectrum distinguishes glioblastomas from low grade gliomas and infiltrative component of glioblastomas , 2013, Biomedical optics express.
[175] O. Kallioniemi,et al. FusionCatcher – a tool for finding somatic fusion genes in paired-end RNA-sequencing data , 2014, bioRxiv.
[176] Dima Suki,et al. Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[177] N. Blüthgen,et al. Oncogenic β-catenin and PIK3CA instruct network states and cancer phenotypes in intestinal organoids , 2017, The Journal of cell biology.
[178] Henry Brem,et al. Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma. , 2014, Neuro-oncology.
[179] E. McVeigh,et al. Detection of human brain cancer infiltration ex vivo and in vivo using quantitative optical coherence tomography , 2015, Science Translational Medicine.
[180] Chen-Yang Shen,et al. FGFR2 regulates Mre11 expression and double-strand break repair via the MEK-ERK-POU1F1 pathway in breast tumorigenesis. , 2015, Human molecular genetics.
[181] Adam Kiezun,et al. Complementary genomic approaches highlight the PI3K/mTOR pathway as a common vulnerability in osteosarcoma , 2014, Proceedings of the National Academy of Sciences.
[182] M. Snuderl,et al. Rapid Intraoperative Diagnosis of Pediatric Brain Tumors Using Stimulated Raman Histology. , 2018, Cancer research.
[183] G A Colditz,et al. Physical Activity, Obesity, and Risk for Colon Cancer and Adenoma in Men , 1995, Annals of Internal Medicine.
[184] Gonçalo R. Abecasis,et al. Unified representation of genetic variants , 2015, Bioinform..
[185] Geoffrey S. Tobias,et al. Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer , 2009, Nature Genetics.
[186] Qingxia Chen,et al. The therapy is making me sick: how online portal communications between breast cancer patients and physicians indicate medication discontinuation , 2018, J. Am. Medical Informatics Assoc..
[187] Alfredo Quinones-Hinojosa,et al. The Value of Extent of Resection of Glioblastomas: Clinical Evidence and Current Approach , 2014, Current Neurology and Neuroscience Reports.
[188] M. Nielsen,et al. The Length Distribution of Class I–Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele–Specific Binding Preference , 2016, The Journal of Immunology.
[189] S. Leivonen,et al. Hypoxia-activated Smad3-specific Dephosphorylation by PP2A* , 2009, The Journal of Biological Chemistry.
[190] Martin E. Fernandez-Zapico,et al. Faculty Opinions recommendation of Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development. , 2015 .
[191] Chen Lin,et al. Temporal Annotation in the Clinical Domain , 2014, TACL.
[192] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[193] Jeffrey E. Lee,et al. A Visually Apparent and Quantifiable CT Imaging Feature Identifies Biophysical Subtypes of Pancreatic Ductal Adenocarcinoma , 2018, Clinical Cancer Research.
[194] Maurizio Zanetti,et al. Neoantigen prediction and the need for validation , 2017, Nature Biotechnology.
[195] Bentzen,et al. Patient-to-Patient Variability in the Expression of Radiation-Induced Normal Tissue Injury. , 1994, Seminars in radiation oncology.
[196] Yoram Singer,et al. BoosTexter: A Boosting-based System for Text Categorization , 2000, Machine Learning.
[197] Michael Gertz,et al. Multilingual and cross-domain temporal tagging , 2012, Language Resources and Evaluation.
[198] J. Brooks,et al. New Paradigms for Patient-Centered Outcomes Research in Electronic Medical Records: An Example of Detecting Urinary Incontinence Following Prostatectomy , 2016, EGEMS.
[199] Xinyu Zhang,et al. CloudNeo: a cloud pipeline for identifying patient-specific tumor neoantigens , 2017, Bioinform..
[200] Li Ding,et al. Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines. , 2018, Cell systems.
[201] Hong-Jun Yoon,et al. Coarse-to-fine multi-task training of convolutional neural networks for automated information extraction from cancer pathology reports , 2018, 2018 IEEE EMBS International Conference on Biomedical & Health Informatics (BHI).
[202] Anthony N. Nguyen,et al. Automatic Diagnosis Coding of Radiology Reports: A Comparison of Deep Learning and Conventional Classification Methods , 2017, BioNLP.
[203] Alfredo Quinones-Hinojosa,et al. When gross total resection of a glioblastoma is possible, how much resection should be achieved? , 2014, World neurosurgery.
[204] R. Emerson,et al. Radiotherapy induces responses of lung cancer to CTLA-4 blockade , 2018, Nature Medicine.
[205] Y. Asmann,et al. High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma , 2017, Blood Cancer Journal.
[206] P. Lønning,et al. Genomic Evolution of Breast Cancer Metastasis and Relapse , 2017, Cancer cell.
[207] Marco Foiani,et al. Regulation of DNA repair throughout the cell cycle , 2008, Nature Reviews Molecular Cell Biology.
[208] P. Agius,et al. Immunogenic neoantigens derived from gene fusions stimulate T cell responses , 2019, Nature Medicine.
[209] T. McMillan,et al. The radiobiology of human cells and tissues. In vitro radiosensitivity. The picture has changed in the 1980s. , 1989, International journal of radiation biology.
[210] B. Wouters,et al. Apoptosis, p53, and tumor cell sensitivity to anticancer agents. , 1999, Cancer research.
[211] Antonio Pertusa,et al. Learning Eligibility in Cancer Clinical Trials using Deep Neural Networks , 2018, Applied Sciences.
[212] Benjamin D. Smith,et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. , 2014, Cancer research.
[213] C. Wirtz,et al. Histopathological Insights on Imaging Results of Intraoperative Magnetic Resonance Imaging, 5-Aminolevulinic Acid, and Intraoperative Ultrasound in Glioblastoma Surgery , 2017, Neurosurgery.
[214] B Palcic,et al. Reduced oxygen enhancement ratio at low doses of ionizing radiation. , 1984, Radiation research.
[215] F. Cunningham,et al. The Ensembl Variant Effect Predictor , 2016, Genome Biology.
[216] David Gfeller,et al. Deciphering HLA-I motifs across HLA peptidomes improves neo-antigen predictions and identifies allostery regulating HLA specificity , 2017, bioRxiv.
[217] T. Nakano,et al. Inter-assay precision of clonogenic assays for radiosensitivity in cancer cell line A549 , 2018, Oncotarget.
[218] Fupan Yao,et al. Tissue specificity of in vitro drug sensitivity , 2016, bioRxiv.
[219] Pornpimol Charoentong,et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade , 2016, bioRxiv.
[220] Emanuel J. V. Gonçalves,et al. A Landscape of Pharmacogenomic Interactions in Cancer , 2016, Cell.
[221] David L. Masica,et al. Exome-Scale Discovery of Hotspot Mutation Regions in Human Cancer Using 3D Protein Structure. , 2016, Cancer research.
[222] Zoubin Ghahramani,et al. A Theoretically Grounded Application of Dropout in Recurrent Neural Networks , 2015, NIPS.
[223] J. Willmann,et al. Thy1-Targeted Microbubbles for Ultrasound Molecular Imaging of Pancreatic Ductal Adenocarcinoma , 2018, Clinical Cancer Research.
[224] Wen-wai Yim,et al. Natural Language Processing in Oncology: A Review. , 2016, JAMA oncology.
[225] Elaine R. Mardis,et al. Applications of Immunogenomics to Cancer , 2017, Cell.
[226] Michael C. Rusch,et al. CREST maps somatic structural variation in cancer genomes with base-pair resolution , 2011, Nature Methods.
[227] Moriah H Nissan,et al. OncoKB: A Precision Oncology Knowledge Base. , 2017, JCO precision oncology.
[228] Lawrence T. Post,et al. American College of Surgeons , 2020, Definitions.
[229] Benjamin Haibe-Kains,et al. Inconsistency in large pharmacogenomic studies , 2013, Nature.
[230] Andrew H. Beck,et al. PharmacoGx: an R package for analysis of large pharmacogenomic datasets , 2015, Bioinform..
[231] P. Hieter,et al. Synthetic lethality and cancer , 2017, Nature Reviews Genetics.
[232] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[233] J. Manson,et al. Pancreatic Cancer Risk Associated with Prediagnostic Plasma Levels of Leptin and Leptin Receptor Genetic Polymorphisms. , 2016, Cancer research.
[234] E. Hall,et al. Radiation oncology: a century of achievements , 2004, Nature Reviews Cancer.
[235] Steven J. M. Jones,et al. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients , 2018, Cancer cell.
[236] Oladimeji Farri,et al. Comparative effectiveness of convolutional neural network (CNN) and recurrent neural network (RNN) architectures for radiology text report classification , 2019, Artif. Intell. Medicine.
[237] C. Zahnow,et al. Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer. , 2017, Cancer discovery.
[238] Kam Y. J. Zhang,et al. Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma , 2010, Nature.
[239] William R. Hogan,et al. Natural Language Processing methods and systems for biomedical ontology learning , 2011, J. Biomed. Informatics.
[240] Deborah Hix,et al. The immune epitope database (IEDB) 3.0 , 2014, Nucleic Acids Res..
[241] Chao Yang,et al. A Survey on Deep Transfer Learning , 2018, ICANN.
[242] Jean-Pierre Gillet,et al. The clinical relevance of cancer cell lines. , 2013, Journal of the National Cancer Institute.
[243] L. Robison,et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. , 1996, The New England journal of medicine.
[244] K. Fujii,et al. Possibility of using laser spectroscopy for the intraoperative detection of nonfluorescing brain tumors and the boundaries of brain tumor infiltrates. Technical note. , 2006, Journal of neurosurgery.
[245] S. Gudbjörnsdottir,et al. Pattern of increasing HbA1c levels in patients with diabetes mellitus before clinical detection of pancreatic cancer – a population-based nationwide case-control study , 2015, Acta oncologica.
[246] Timothy Miller,et al. A BERT-based Universal Model for Both Within- and Cross-sentence Clinical Temporal Relation Extraction , 2019, Proceedings of the 2nd Clinical Natural Language Processing Workshop.
[247] G. Linette,et al. Neoantigen Vaccines Pass the Immunogenicity Test. , 2017, Trends in molecular medicine.
[248] Jean-Emmanuel Bibault,et al. Personalized radiation therapy and biomarker-driven treatment strategies: a systematic review , 2013, Cancer and Metastasis Reviews.
[249] L. Cantley,et al. The Multifaceted Role of Chromosomal Instability in Cancer and Its Microenvironment , 2018, Cell.
[250] Olivier Elemento,et al. Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome , 2019, BMC Bioinformatics.
[251] Dina Demner-Fushman,et al. Automated classification of eligibility criteria in clinical trials to facilitate patient-trial matching for specific patient populations , 2017, J. Am. Medical Informatics Assoc..
[252] J. Marine,et al. p53 Reactivation by PRIMA-1(Met) (APR-246) sensitises (V600E/K)BRAF melanoma to vemurafenib. , 2016, European journal of cancer.
[253] M. Cabana,et al. Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement. , 2019, JAMA.
[254] J. Sidney,et al. Genomic and bioinformatic profiling of mutational neoepitopes reveals new rules to predict anticancer immunogenicity , 2014, The Journal of experimental medicine.
[255] Kirk Roberts,et al. A FrameNet for Cancer Information in Clinical Narratives: Schema and Annotation , 2018, LREC.
[256] Gabriela Alexe,et al. Characterizing genomic alterations in cancer by complementary functional associations , 2016, Nature Biotechnology.
[257] G. Ottaviani,et al. The epidemiology of osteosarcoma. , 2009, Cancer treatment and research.
[258] Ziding Feng,et al. Model to Determine Risk of Pancreatic Cancer in Patients With New-Onset Diabetes. , 2018, Gastroenterology.
[259] Hiroshi Iseki,et al. Precise comparison of protoporphyrin IX fluorescence spectra with pathological results for brain tumor tissue identification , 2011, Brain Tumor Pathology.
[260] L. Wessels,et al. Pretreatment microRNA Expression Impacting on Epithelial-to-Mesenchymal Transition Predicts Intrinsic Radiosensitivity in Head and Neck Cancer Cell Lines and Patients , 2015, Clinical Cancer Research.
[261] Francisco Azuaje,et al. Computational models for predicting drug responses in cancer research , 2016, Briefings Bioinform..
[262] Scott E. Martin,et al. Reproducible pharmacogenomic profiling of cancer cell line panels , 2016, Nature.
[263] M. Stratton,et al. Clock-like mutational processes in human somatic cells , 2015, Nature Genetics.
[264] X. Xie,et al. Rapid, Label-Free Detection of Brain Tumors with Stimulated Raman Scattering Microscopy , 2013, Science Translational Medicine.
[265] O. Lund,et al. NetMHCpan, a method for MHC class I binding prediction beyond humans , 2008, Immunogenetics.
[266] Z. Szallasi,et al. Spatial and temporal diversity in genomic instability processes defines lung cancer evolution , 2014, Science.
[267] J. Greenbaum,et al. Improved methods for predicting peptide binding affinity to MHC class II molecules , 2018, Immunology.
[268] Raymond M. Moore,et al. Association Between Inherited Germline Mutations in Cancer Predisposition Genes and Risk of Pancreatic Cancer , 2018, JAMA.
[269] S. Salzberg,et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads , 2015, Nature Biotechnology.
[270] U. Şahin,et al. Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices , 1999, Nature Biotechnology.
[271] George Coukos,et al. Mass spectrometry-based antigen discovery for cancer immunotherapy. , 2016, Current opinion in immunology.
[272] S. Altekruse,et al. Outcomes for children and adolescents with cancer: challenges for the twenty-first century. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[273] Marcia Irene Canto,et al. Screening for Pancreatic Cancer. , 2016, The Surgical clinics of North America.
[274] Carol Friedman,et al. A broad-coverage natural language processing system , 2000, AMIA.
[275] Martin F. Cohen,et al. Impact of the HITECH financial incentives on EHR adoption in small, physician-owned practices , 2016, Int. J. Medical Informatics.
[276] Paul G. Thomas,et al. Pediatric patients with acute lymphoblastic leukemia generate abundant and functional neoantigen-specific CD8+ T cell responses , 2019, Science Translational Medicine.
[277] L. Bullinger,et al. The patients’ view: impact of the extent of resection, intraoperative imaging, and awake surgery on health-related quality of life in high-grade glioma patients—results of a multicenter cross-sectional study , 2017, Neurosurgical Review.
[278] M. Bernstein,et al. The role of 5‐aminolevulinic acid in enhancing surgery for high‐grade glioma, its current boundaries, and future perspectives: A systematic review , 2016, Cancer.
[279] Mihai Surdeanu,et al. The Stanford CoreNLP Natural Language Processing Toolkit , 2014, ACL.
[280] Chen Lin,et al. Neural Temporal Relation Extraction , 2017, EACL.
[281] Sunghwan Sohn,et al. Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications , 2010, J. Am. Medical Informatics Assoc..
[282] María Martín,et al. Activities at the Universal Protein Resource (UniProt) , 2013, Nucleic Acids Res..
[283] F. Pirouzmand,et al. Comparison of the reliability of brain lesion localization when using traditional and stereotactic image-guided techniques: a prospective study. , 2005, Journal of neurosurgery.
[284] Serena Nik-Zainal,et al. Mechanisms underlying mutational signatures in human cancers , 2014, Nature Reviews Genetics.
[285] Chen Lin,et al. Multilayered temporal modeling for the clinical domain , 2016, J. Am. Medical Informatics Assoc..
[286] Pedro J Ballester,et al. Systematic assessment of multi-gene predictors of pan-cancer cell line sensitivity to drugs exploiting gene expression data , 2016, bioRxiv.
[287] Hong-Jun Yoon,et al. Deep Learning for Automated Extraction of Primary Sites From Cancer Pathology Reports , 2018, IEEE Journal of Biomedical and Health Informatics.
[288] Girish Chavan,et al. NOBLE – Flexible concept recognition for large-scale biomedical natural language processing , 2016, BMC Bioinformatics.
[289] A. Sivachenko,et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples , 2013, Nature Biotechnology.
[290] D. Silverman,et al. Circulating Leptin and Risk of Pancreatic Cancer: A Pooled Analysis From 3 Cohorts. , 2015, American journal of epidemiology.
[291] F. Rodriguez,et al. Comparative volumetric analysis of the extent of resection of molecularly and histologically distinct low grade gliomas and its role on survival , 2017, Journal of Neuro-Oncology.
[292] C. Harris. A delayed complication of cancer therapy--cancer. , 1979, Journal of the National Cancer Institute.
[293] Nicolai J. Birkbak,et al. Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis. , 2017, The Lancet. Oncology.
[294] Benjamin Schubert,et al. FRED 2: an immunoinformatics framework for Python , 2016, Bioinform..
[295] Chen Lin,et al. Self-training improves Recurrent Neural Networks performance for Temporal Relation Extraction , 2018, Louhi@EMNLP.
[296] Jennifer L. Lund,et al. Comparison of SEER Treatment Data With Medicare Claims , 2016, Medical care.
[297] N. McGranahan,et al. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future , 2017, Cell.
[298] Geoffrey E. Hinton,et al. Learning representations by back-propagating errors , 1986, Nature.
[299] W. Dupont. Converting relative risks to absolute risks: a graphical approach. , 1986, Statistics in medicine.
[300] Brent S. Pedersen,et al. Combating subclonal evolution of resistant cancer phenotypes , 2017, Nature Communications.
[301] Morten Nielsen,et al. Quantitative Predictions of Peptide Binding to Any HLA-DR Molecule of Known Sequence: NetMHCIIpan , 2008, PLoS Comput. Biol..
[302] Morten Nielsen,et al. NetMHCcons: a consensus method for the major histocompatibility complex class I predictions , 2011, Immunogenetics.
[303] D. Kozieł,et al. KRAS, KIT and TP53 mutations in mother’s and daughter’s gastric cardia adenocarcinomas , 2018, Przeglad gastroenterologiczny.
[304] M. Korc,et al. Circulating Leptin and Branched Chain Amino Acids—Correlation with Intraductal Papillary Mucinous Neoplasm Dysplastic Grade , 2018, Journal of Gastrointestinal Surgery.
[305] Marie-Francine Moens,et al. Word-Level Loss Extensions for Neural Temporal Relation Classification , 2018, COLING.
[306] A. Pappo,et al. Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[307] A. Gelrud,et al. Predictors for Pancreatic Cancer Diagnosis Following New-Onset Diabetes Mellitus , 2015, Clinical and translational gastroenterology.
[308] K Tashibu. [Analysis of water content in rat brain using Raman spectroscopy]. , 1990, No to shinkei = Brain and nerve.
[309] Javier A. Jo,et al. Blind End-Member and Abundance Extraction for Multispectral Fluorescence Lifetime Imaging Microscopy Data , 2014, IEEE Journal of Biomedical and Health Informatics.
[310] Tormod Selbekk,et al. Comparison of navigated 3D ultrasound findings with histopathology in subsequent phases of glioblastoma resection , 2008, Acta Neurochirurgica.
[311] K. Lillemoe,et al. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer , 1999, British Journal of Cancer.
[312] E. Mardis,et al. pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens , 2016, Genome Medicine.
[313] S. Bertolone,et al. Intensive induction chemotherapy followed by myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for young children newly‐diagnosed with central nervous system atypical teratoid/rhabdoid tumors: The head start III experience , 2014, Pediatric blood & cancer.
[314] Yong-Chen Lu,et al. Targeting neoantigens for cancer immunotherapy. , 2016, International immunology.
[315] Y. Hoshida,et al. Cancer biomarker discovery and validation. , 2015, Translational cancer research.
[316] Steven J. M. Jones,et al. Comprehensive Characterization of Cancer Driver Genes and Mutations , 2018, Cell.
[317] Aman N. Patel,et al. CONSERTING: integrating copy-number analysis with structural-variation detection , 2015, Nature Methods.
[318] Steven J. M. Jones,et al. The Immune Landscape of Cancer , 2018, Immunity.
[319] Adam A. Margolin,et al. Population-level distribution and putative immunogenicity of cancer neoepitopes , 2017, BMC Cancer.
[320] Kevin Petrecca,et al. A new method using Raman spectroscopy for in vivo targeted brain cancer tissue biopsy , 2018, Scientific Reports.
[321] Ash A. Alizadeh,et al. Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.
[322] Alfredo Quinones-Hinojosa,et al. ASSOCIATION OF SURGICALLY ACQUIRED MOTOR AND LANGUAGE DEFICITS ON OVERALL SURVIVAL AFTER RESECTION OF GLIOBLASTOMA MULTIFORME , 2009, Neurosurgery.
[323] Joshua M. Stuart,et al. The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.
[324] Christopher A. Miller,et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. , 2012, Genome research.
[325] Huitu Liu,et al. MAPK signal pathways in the regulation of cell proliferation in mammalian cells , 2002, Cell Research.
[326] Matthew Scotch,et al. The Yale cTAKES extensions for document classification: architecture and application , 2011, J. Am. Medical Informatics Assoc..
[327] Frank Noé,et al. Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation , 2017, Front. Immunol..
[328] Morten Nielsen,et al. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method , 2007, BMC Bioinformatics.
[329] P. Tamayo,et al. A genetic basis for the variation in the vulnerability of cancer to DNA damage , 2016, Nature Communications.
[330] Morten Nielsen,et al. Gapped sequence alignment using artificial neural networks: application to the MHC class I system , 2016, Bioinform..
[331] C. D. Gelatt,et al. Optimization by Simulated Annealing , 1983, Science.
[332] Zhigang Duan,et al. Limits of observational data in determining outcomes from cancer therapy , 2008, Cancer.
[333] Mechthild Krause,et al. Radiation oncology in the era of precision medicine , 2016, Nature Reviews Cancer.
[334] Jennifer B Dennison,et al. A Plasma-Derived Protein-Metabolite Multiplexed Panel for Early-Stage Pancreatic Cancer , 2018, Journal of the National Cancer Institute.
[335] Alessandro Sette,et al. The Immune Epitope Database 2.0 , 2009, Nucleic Acids Res..
[336] Ming Liu,et al. Accuracy of Raman spectroscopy in differentiating brain tumor from normal brain tissue , 2017, Oncotarget.
[337] Morten Nielsen,et al. Major histocompatibility complex class I binding predictions as a tool in epitope discovery , 2010, Immunology.
[338] H. El‐Serag,et al. A prospective study of soluble receptor for advanced glycation end products and adipokines in association with pancreatic cancer in postmenopausal women , 2018, Cancer medicine.
[339] Yoav Goldberg,et al. A Primer on Neural Network Models for Natural Language Processing , 2015, J. Artif. Intell. Res..
[340] John F. Canny,et al. A Computational Approach to Edge Detection , 1986, IEEE Transactions on Pattern Analysis and Machine Intelligence.
[341] W. Hahn,et al. Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer , 2018, Genetics in Medicine.
[342] David Boulware,et al. A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation. , 2009, International journal of radiation oncology, biology, physics.
[343] Colin N. Dewey,et al. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.
[344] Martín Abadi,et al. TensorFlow: Large-Scale Machine Learning on Heterogeneous Distributed Systems , 2016, ArXiv.
[345] Graham A. Colditz,et al. The Nurses' Health Study: lifestyle and health among women , 2005, Nature Reviews Cancer.
[346] S. Joshua Swamidass,et al. Accounting for proximal variants improves neoantigen prediction , 2018, Nature Genetics.
[347] Eric Fosler-Lussier,et al. Identification, characterization, and grounding of gradable terms in clinical text , 2016, BioNLP@ACL.
[348] David K. Vawdrey,et al. HARVEST, a longitudinal patient record summarizer , 2014, J. Am. Medical Informatics Assoc..
[349] Morten Nielsen,et al. Dataset size and composition impact the reliability of performance benchmarks for peptide-MHC binding predictions , 2014, BMC Bioinformatics.
[350] Robert Budden,et al. TCGA Expedition: A Data Acquisition and Management System for TCGA Data , 2016, PloS one.
[351] Timothy A. Miller,et al. DeepPhe: A Natural Language Processing System for Extracting Cancer Phenotypes from Clinical Records. , 2017, Cancer research.
[352] S. Liyanarachchi,et al. MicroRNA-3151 inactivates TP53 in BRAF-mutated human malignancies , 2015, Proceedings of the National Academy of Sciences.
[353] A. Oshlack,et al. JAFFA: High sensitivity transcriptome-focused fusion gene detection , 2015, Genome Medicine.
[354] G. Petersen,et al. Familial Pancreatic Adenocarcinoma. , 2015, Hematology/oncology clinics of North America.
[355] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[356] Christopher A. Miller,et al. Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy. , 2016, Cancer discovery.
[357] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[358] Young Saing Kim,et al. Concordance Rate between Clinicians and Watson for Oncology among Patients with Advanced Gastric Cancer: Early, Real-World Experience in Korea , 2019, Canadian journal of gastroenterology & hepatology.
[359] T. Kietzmann,et al. Antioxidant responses and cellular adjustments to oxidative stress , 2015, Redox biology.
[360] A. Stewart,et al. Comparison of Cases Captured in the National Cancer Data Base with Those in Population-based Central Cancer Registries , 2013, Annals of surgical oncology.
[361] Jürgen Schmidhuber,et al. Long Short-Term Memory , 1997, Neural Computation.
[362] John F. Hurdle,et al. Extracting Information from Textual Documents in the Electronic Health Record: A Review of Recent Research , 2008, Yearbook of Medical Informatics.
[363] I. Olkin,et al. Meta-analysis of observational studies in epidemiology - A proposal for reporting , 2000 .
[364] Sherri Rose,et al. Classifying Lung Cancer Severity with Ensemble Machine Learning in Health Care Claims Data , 2017, MLHC.
[365] Pierre Zweigenbaum,et al. Clinical Natural Language Processing in languages other than English: opportunities and challenges , 2018, Journal of Biomedical Semantics.
[366] Wendy S. W. Wong,et al. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs , 2012, Bioinform..
[367] Morten Nielsen,et al. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction , 2009, BMC Bioinformatics.
[368] Knut Reinert,et al. Flexbar 3.0 ‐ SIMD and multicore parallelization , 2017, Bioinform..
[369] Mitchell H Gail,et al. On criteria for evaluating models of absolute risk. , 2005, Biostatistics.
[370] J. Manson,et al. Inflammatory Plasma Markers and Pancreatic Cancer Risk: A Prospective Study of Five U.S. Cohorts , 2013, Cancer Epidemiology, Biomarkers & Prevention.
[371] Pengfei Li,et al. MDM2 Acts Downstream of p53 as an E3 Ligase to Promote FOXO Ubiquitination and Degradation* , 2009, Journal of Biological Chemistry.
[372] Christian Wiesmann,et al. Antibody-based targeting of FGFR3 in bladder carcinoma and t(4;14)-positive multiple myeloma in mice. , 2009, The Journal of clinical investigation.
[373] S. Nelson,et al. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation , 2010, Nature.
[374] Steven Bethard,et al. Efficient identification of nationally mandated reportable cancer cases using natural language processing and machine learning , 2016, J. Am. Medical Informatics Assoc..
[375] F. Bova,et al. The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma. , 2017, Journal of neurosurgery.
[376] Fan Zhang,et al. Syn-Lethality: An Integrative Knowledge Base of Synthetic Lethality towards Discovery of Selective Anticancer Therapies , 2013, 2013 IEEE International Conference on Bioinformatics and Biomedicine.
[377] J. Gartner,et al. Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers , 2019, The Journal of clinical investigation.
[378] Pascal Vincent,et al. Representation Learning: A Review and New Perspectives , 2012, IEEE Transactions on Pattern Analysis and Machine Intelligence.
[379] Mariza de Andrade,et al. Probability of pancreatic cancer following diabetes: a population-based study. , 2005, Gastroenterology.
[380] Alessandro Sette,et al. The Immune Epitope Database (IEDB): 2018 update , 2018, Nucleic Acids Res..
[381] G A Colditz,et al. Physical activity, obesity, height, and the risk of pancreatic cancer. , 2001, JAMA.
[382] Drew J. Adams,et al. Radiotherapy in the Era of Precision Medicine. , 2015, Seminars in radiation oncology.
[383] Mikael Karlsson,et al. The effects of hypoxia on the theoretical modelling of tumour control probability , 2005, Acta oncologica.
[384] I. Lewis,et al. Osteosarcoma treatment - where do we stand? A state of the art review. , 2014, Cancer treatment reviews.
[385] Clemencia Pinilla,et al. Derivation of an amino acid similarity matrix for peptide:MHC binding and its application as a Bayesian prior , 2009, BMC Bioinformatics.
[386] Francesco Iorio,et al. Logic models to predict continuous outputs based on binary inputs with an application to personalized cancer therapy , 2016, Scientific Reports.
[387] A. Bouchard-Côté,et al. PyClone: statistical inference of clonal population structure in cancer , 2014, Nature Methods.
[388] Mingming Jia,et al. COSMIC: somatic cancer genetics at high-resolution , 2016, Nucleic Acids Res..
[389] Benjamin Haibe-Kains,et al. Genomic biomarkers for precision radiation medicine. , 2017, The Lancet. Oncology.
[390] Michele A. Busby,et al. Supplementary Materials for Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification , 2018 .
[391] Alfredo Quinones-Hinojosa,et al. The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors? , 2014, Journal of Neuro-Oncology.
[392] Jun S. Liu,et al. Genome-Scale Signatures of Gene Interaction from Compound Screens Predict Clinical Efficacy of Targeted Cancer Therapies. , 2018, Cell systems.
[393] Naoaki Okazaki,et al. Investigating the Challenges of Temporal Relation Extraction from Clinical Text , 2018, Louhi@EMNLP.
[394] Regina Barzilay,et al. Using machine learning to parse breast pathology reports , 2016, bioRxiv.
[395] Franck Dernoncourt,et al. Comparing deep learning and concept extraction based methods for patient phenotyping from clinical narratives , 2018, PloS one.
[396] Diana Tichy,et al. Performance Evaluation of MHC Class-I Binding Prediction Tools Based on an Experimentally Validated MHC–Peptide Binding Data Set , 2019, Cancer Immunology Research.
[397] Christopher A. Miller,et al. Tumor Evolution in Two Patients with Basal-like Breast Cancer: A Retrospective Genomics Study of Multiple Metastases , 2016, PLoS medicine.
[398] Cong Liu,et al. [Functional Analysis of DNA Damage Repair Factor WDR70 and Its Mutation in Ovarian Cancer]. , 2016, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.
[399] N. Hacohen,et al. HLA-Binding Properties of Tumor Neoepitopes in Humans , 2014, Cancer Immunology Research.
[400] S. Ramaswamy,et al. Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.
[401] Tomas Mikolov,et al. Bag of Tricks for Efficient Text Classification , 2016, EACL.
[402] Kiran C. Bobba,et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.
[403] G. Steel,et al. The radioresponsiveness of human tumours and the initial slope of the cell survival curve. , 1984, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[404] T. Ideker,et al. MHC-I Genotype Restricts the Oncogenic Mutational Landscape , 2017, Cell.
[405] Morten Nielsen,et al. Automated benchmarking of peptide-MHC class I binding predictions , 2015, Bioinform..
[406] Levi A Garraway,et al. Genomics-driven oncology: framework for an emerging paradigm. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[407] Patrick Aloy,et al. Drug sensitivity in cancer cell lines is not tissue-specific , 2015, Molecular Cancer.
[408] F. Wenz,et al. Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization , 2016, International journal of molecular sciences.
[409] K. Cibulskis,et al. Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia. , 2014, Blood.
[410] Alison P. Klein,et al. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21 , 2016, Oncotarget.
[411] Karen Margolis,et al. Disclosure of Potential Conflicts of Interest , 2014 .
[412] Sridhar Ramaswamy,et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..
[413] Won-Suk Lee,et al. Assessing Concordance With Watson for Oncology, a Cognitive Computing Decision Support System for Colon Cancer Treatment in Korea. , 2018, JCO clinical cancer informatics.
[414] Eduard Schreibmann,et al. Semi-Automated Volumetric and Morphological Assessment of Glioblastoma Resection with Fluorescence-Guided Surgery , 2016, Molecular Imaging and Biology.
[415] Jing Ma,et al. Rise and fall of subclones from diagnosis to relapse in pediatric B-acute lymphoblastic leukaemia , 2015, Nature Communications.
[416] T. Bumgarner. Pediatric And Adolescent Osteosarcoma , 2016 .
[417] J P Freyer,et al. Oxygen enhancement ratio as a function of dose and cell cycle phase for radiation-resistant and sensitive CHO cells. , 1991, Radiation research.
[418] Michael R. Crusoe,et al. Common Workflow Language , 2015 .
[419] Hyun Cheol Chung,et al. Identification of a radiosensitivity signature using integrative metaanalysis of published microarray data for NCI-60 cancer cells , 2011, BMC Genomics.